FDA Selects Mission: Cure to Develop Pancreatitis Trial Endpoint
Mission: Cure joins the FDA’s Rare Disease Endpoint Advancement Pilot Program to develop a pancreatitis flare endpoint for clinical trials.
Mission: Cure joins the FDA’s Rare Disease Endpoint Advancement Pilot Program to develop a pancreatitis flare endpoint for clinical trials.